-inc-logo-1200x675.png){kind=logo}
Shares of Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) traded down 1.5% during trading on Wednesday . The stock traded as low as $6.23 and last traded at $6.40. 914,451 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 3,376,665 shares. The stock had previously closed at $6.50.
Mind Medicine (MindMed) Stock Down 3.7 %
The business has a 50 day moving average of $7.45 and a 200-day moving average of $6.94.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Further Reading
- Five stocks we like better than Mind Medicine (MindMed)
- How to Calculate Stock Profit
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to Capture the Benefits of Dividend Increases
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to Use the MarketBeat Excel Dividend Calculator
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
